Literature DB >> 25620113

Fetus absorbed dose evaluation in head and neck radiotherapy procedures of pregnant patients.

Etieli C da Costa1, Luiz Antonio R da Rosa2, Delano Valdivino S Batista3.   

Abstract

In this work the head and neck cancer treatment of a pregnant patient was experimentally simulated. A female anthropomorphic Alderson phantom was used and the absorbed dose to the fetus was evaluated protecting the patient's abdomen with a 7cm lead layer and using no abdomen shielding. The target volume dose was 50Gy. The fetus doses evaluated with and without the lead shielding were, respectively, 0.52±0.039 and 0.88±0.052cGy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fetus absorbed dose; Head and neck radiotherapy; Pregnant patient; Thermoluminescent dosimetry

Mesh:

Year:  2015        PMID: 25620113     DOI: 10.1016/j.apradiso.2015.01.013

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  1 in total

1.  Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy.

Authors:  Wataru Takahashi; Kanabu Nawa; Akihiro Haga; Hideomi Yamashita; Toshikazu Imae; Mami Ogita; Kae Okuma; Osamu Abe; Keiichi Nakagawa
Journal:  Clin Transl Radiat Oncol       Date:  2019-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.